Security · CUSIP 55083R203
LYELL IMMUNOPHARMA INC
COM NEW · institutional ownership from 13F filings
13F holders
65
Shares held
6.8M
Value held
$60.3M
New / sold out
65 / 0
Added / reduced
0 / 0
net +6.8M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2025
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| ARCH Venture Management, LLC | 1,820,634 | $16.1M | 5.39% |
| Foresite Capital Management IV, LLC | 800,399 | $7.1M | 5.72% |
| Almitas Capital LLC | 579,997 | $5.1M | 1.29% |
| venBio Partners LLC | 473,479 | $4.2M | 3.65% |
| VANGUARD GROUP INC | 442,626 | $3.9M | 0.00% |
| Foresite Capital Management V, LLC | 406,652 | $3.6M | 4.45% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 306,059 | $2.7M | 0.00% |
| Alphabet Inc. | 293,256 | $2.6M | 0.12% |
| CITADEL ADVISORS LLC | 271,283 | $2.4M | 0.00% |
| HSG Holding Ltd | 152,299 | $1.3M | 0.07% |
55 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| ARCH Venture Management, LLC | New | +1,820,634 | – |
| Foresite Capital Management IV, LLC | New | +800,399 | – |
| Almitas Capital LLC | New | +579,997 | – |
| venBio Partners LLC | New | +473,479 | – |
| VANGUARD GROUP INC | New | +442,626 | – |
| Foresite Capital Management V, LLC | New | +406,652 | – |
| PRICE T ROWE ASSOCIATES INC /MD/ | New | +306,059 | – |
| Alphabet Inc. | New | +293,256 | – |
| CITADEL ADVISORS LLC | New | +271,283 | – |
| HSG Holding Ltd | New | +152,299 | – |
55 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sellers
Nothing to show.